Continuous Analyte Monitoring With ML Alerts for Readmission Reduction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current monitoring techniques for chronic or acute illnesses are often invasive, reactive, and infrequent, leading to missed early warning signs and gaps in patient data, which can result in delayed or missed diagnoses and increased patient readmission rates.

Innovation Solution

A continuous analyte monitoring system that utilizes machine learning to predict patient outcomes based on real-time analyte data, such as lactate and glucose levels, and provides alerts and recommendations to healthcare providers to facilitate timely interventions and reduce readmission events.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If continuous analyte monitoring is implemented, then early detection of patient deterioration is improved, but device complexity and resource intensity increase

Engineering Contradiction:
Improveearly detection of patient deteriorationVSAvoidresource intensity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent replaces complex mechanical monitoring systems with machine learning algorithms that analyze continuous analyte data. The ML model predicts patient outcomes by processing sensor data, eliminating the need for complex mechanical intervention systems while improving early detection capability.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The system implements self-monitoring through continuous analyte sensors that automatically track patient conditions without requiring manual intervention. The machine learning model autonomously analyzes data and generates predictions, reducing the need for continuous human resource involvement while maintaining high reliability.

Inventive Principle:
Principle #25Self-service

2Measurement precision

If continuous monitoring is used, then measurement precision and early warning detection are improved, but loss of time and data processing complexity increase

Engineering Contradiction:
Improveanalyte level detection accuracyVSAvoiddata processing time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The machine learning model is pre-trained on extensive patient data before deployment. This preliminary training enables the model to rapidly process continuous analyte data in real-time without requiring complex analysis during patient monitoring, thus maintaining high measurement precision while minimizing data processing time.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system implements continuous feedback loops where analyte data is constantly monitored and fed into the ML model for real-time prediction updates. This feedback mechanism allows the system to maintain high measurement precision through continuous analysis while optimizing processing speed through iterative model refinement.

Inventive Principle:
Principle #23Feedback

3Device complexity

If reactive monitoring with gaps is used, then device complexity is reduced, but loss of information about patient condition increases

Engineering Contradiction:
Improvemonitoring system simplicityVSAvoidpatient condition data
Core Design Contradiction:
Device complexityVSLoss of information

Solution Approach 1:

The patent implements continuous analyte monitoring that eliminates gaps in data collection. The system continuously measures analyte levels and feeds data to the machine learning model, ensuring uninterrupted information flow about patient condition while maintaining manageable system complexity through automated processing.

Inventive Principle:
Principle #20Continuity of useful action

Data Source

PatentUS20250299818A1Deployment and use of a continuous analyte monitoring system for improved home monitoring and readmission optimization
Publication Date: 2025.09.25 ABBOTT DIABETES CARE INC
  • US20250299818A1 patent drawing
  • US20250299818A1 patent drawing
  • US20250299818A1 patent drawing

AI summary

Disclosed herein are system, method, and computer program product embodiments to an improved alert and recommendation system for reducing patient readmission via the detection and treatment of patient conditions based on continuous analyte data. The disclosed techniques utilize analyte data, such as lactate, glucose, and creatinine, provided from a continuous analyte sensor to predict patient outcomes and generate recommendations for reducing patient readmission in a hospital and home setting. The disclosed system allows for early and non-invasive prediction of patient outcomes and the subsequent generation of recommended actions to facilitate patient intervention with the goal of reducing readmission of the patient.